v3.25.2
Composition of Certain Consolidated Financial Statement Line Items (Tables)
6 Months Ended
Jun. 30, 2025
Composition of Certain Consolidated Financial Statement Line Items  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

JUNE 30, 

DECEMBER 31, 

    

2025

    

2024

    

Accrued compensation

$

5,589

$

7,290

Accrued research and development expenses

 

9,679

 

5,460

Accrued clinical expenses

8,000

7,025

Accrued professional services

2,884

2,918

Accrued other liabilities

 

1,227

 

3,606

Total accrued expenses and other current liabilities

$

27,379

$

26,299